TNAM
Terra Nova Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
528
-266
| -34% | -$108K | 0.15% | 86 |
|
|
2025
Q1 | $395K | Sell |
794
-47
| -6% | -$23.4K | 0.31% | 62 |
|
|
2024
Q4 | $438K | Sell |
841
-2,211
| -72% | -$1.15M | 0.33% | 64 |
|
|
2024
Q3 | $1.89M | Sell |
3,052
-251
| -8% | -$155K | 1.4% | 33 |
|
|
2024
Q2 | $1.83M | Sell |
3,303
-19
| -0.6% | -$10.5K | 1.44% | 30 |
|
|
2024
Q1 | $1.93M | Buy |
3,322
+1
| +0% | +$581 | 1.54% | 32 |
|
|
2023
Q4 | $1.76M | Sell |
3,321
-567
| -15% | -$301K | 1.55% | 29 |
|
|
2023
Q3 | $2.03M | Hold |
3,888
| – | – | 1.85% | 20 |
|
|
2023
Q2 | $2.03M | Buy |
3,888
+12
| +0.3% | +$6.26K | 1.85% | 20 |
|
|
2023
Q1 | $2.23M | Sell |
3,876
-48
| -1% | -$27.7K | 2.19% | 13 |
|
|
2022
Q4 | $2.16M | Sell |
3,924
-194
| -5% | -$107K | 2.27% | 8 |
|
|
2022
Q3 | $2.09M | Buy |
4,118
+75
| +2% | +$38K | 2.28% | 12 |
|
|
2022
Q2 | $2.2M | Sell |
4,043
-105
| -3% | -$57.1K | 2.44% | 11 |
|
|
2022
Q1 | $2.45M | Sell |
4,148
-1,033
| -20% | -$610K | 2.28% | 14 |
|
|
2021
Q4 | $3.46M | Buy |
5,181
+64
| +1% | +$42.7K | 2.59% | 8 |
|
|
2021
Q3 | $2.92M | Buy |
5,117
+191
| +4% | +$109K | 2.35% | 10 |
|
|
2021
Q2 | $2.49M | Sell |
4,926
-296
| -6% | -$149K | 2.13% | 14 |
|
|
2021
Q1 | $2.38M | Sell |
5,222
-627
| -11% | -$286K | 2.11% | 14 |
|
|
2020
Q4 | $2.72M | Buy |
+5,849
| New | +$2.72M | 2.75% | 12 |
|
|
2018
Q4 | $1.15M | Sell |
5,140
-973
| -16% | -$218K | 3.1% | 14 |
|
|
2018
Q3 | $1.49M | Hold |
6,113
| – | – | 2.26% | 18 |
|
|
2018
Q2 | $1.27M | Buy |
6,113
+399
| +7% | +$82.6K | 2.19% | 21 |
|
|
2018
Q1 | $1.18M | Buy |
5,714
+140
| +3% | +$28.9K | 2.09% | 22 |
|
|
2017
Q4 | $1.06M | Buy |
5,574
+748
| +15% | +$142K | 1.84% | 27 |
|
|
2017
Q3 | $913K | Buy |
4,826
+55
| +1% | +$10.4K | 1.87% | 27 |
|
|
2017
Q2 | $832K | Buy |
4,771
+131
| +3% | +$22.8K | 1.58% | 30 |
|
|
2017
Q1 | $713K | Buy |
+4,640
| New | +$713K | 1.43% | 36 |
|